Bright Minds Biosciences Inc. (NASDAQ: DRUG)
$1.00
-0.0250 ( -2.45% ) 9.7K
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
Market Data
Open
$1.00
Previous close
$1.02
Volume
9.7K
Market cap
$4.78M
Day range
$1.05 - $1.07
52 week range
$0.93 - $6.44
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 8 | May 17, 2024 |
6-k | Quarterly Reports | 13 | May 17, 2024 |
6-k | Quarterly Reports | 8 | Feb 13, 2024 |
20-f | Annual reports | 81 | Dec 29, 2023 |
6-k | Quarterly Reports | 3 | Dec 26, 2023 |
6-k | Quarterly Reports | 3 | Dec 08, 2023 |
6-k | Quarterly Reports | 8 | Aug 15, 2023 |
6-k | Quarterly Reports | 3 | Aug 08, 2023 |
6-k | Quarterly Reports | 3 | Jul 20, 2023 |
6-k | Quarterly Reports | 3 | Jul 12, 2023 |